Skip to content

Careers
Contact Us
Search for:

Home
About
- The COUR Team
- Medical & Science Partners
Technology
- Cour Nanoparticle Platform
Therapeutic Areas
Pipeline
Partners & Collaborators
News & Publications
Videos

Cour Pharmaceuticals

Home > News & Publications > Cour Pharma Presents Scientific Poster on Breakthrough Celiac Treatment at 16th Annual International Celiac Disease Symposium

Share
Print

Cour Pharma Presents Scientific Poster on Breakthrough Celiac Treatment at 16th Annual International Celiac Disease Symposium

Posted December 3, 2015April 6, 2020 Axxiem

Download Poster Here

Post navigation

⟵Cour Pharmaceuticals Releases Data on Potential Breakthrough Treatment for Celiac Disease

Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis⟶

Leave a Reply Cancel reply

You must be logged in to post a comment.

888-551-COUR
888-551-2687

Technology

Technology
Cour Nanoparticle Platform

Videos
Technology
Autoimmune Disease
Food and Environmental Allergies
Gene Therapy

Therapeutic Areas

Therapeutic Areas
Autoimmune: Celiac Disease
Food and Environmental Allergies: Peanut
Rare Diseases: Primary Biliary Cholangitis
Gene Therapy

Pipeline

Pipeline
Celiac Disease (CNP-101/TAK-101)
Peanut Allergy (CNP-201)
Primary Biliary Cholangitis (CNP-104)
Gene Therapy (CNP-AAVC)

close ×

About
Partners & Collaborators
News & Publications
Careers
Contact Us
Sitemap
Videos

Website by Axxiem

© Copyright . All Right Reserved

Privacy | Terms of Use